[4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate

C92H142N16O14S — CID 158889244

IUPAC[4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate
SMILESCCCCCCCCCCCCCCCCNC(=O)CN(CC)C(=O)CCCCCCC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCCNC(N)N)CC(=O)C(CS)NC(=O)C(CCCNC(N)N)CC(=O)C1CCCN(C(=O)C(NC(=O)C(CC(=O)C(NC(=O)CCCOC=O)C(C)O)Cc2cnc[nH]2)C(c2ccccc2)c2ccccc2)C1
InChIInChI=1S/C92H142N16O14S/c1-4-6-7-8-9-10-11-12-13-14-15-16-19-30-47-98-82(116)60-107(5-2)83(117)46-27-18-17-26-44-77(111)75(53-71-57-101-74-43-29-28-42-73(71)74)103-87(118)68(40-32-49-100-92(95)96)55-79(113)76(61-123)104-88(119)67(39-31-48-99-91(93)94)54-78(112)69-41-33-50-108(59-69)90(121)86(84(65-35-22-20-23-36-65)66-37-24-21-25-38-66)106-89(120)70(52-72-58-97-62-102-72)56-80(114)85(64(3)110)105-81(115)45-34-51-122-63-109/h20-25,28-29,35-38,42-43,57-58,62-64,67-70,75-76,84-86,91-92,99-101,110,123H,4-19,26-27,30-34,39-41,44-56,59-61,93-96H2,1-3H3,(H,97,102)(H,98,116)(H,103,118)(H,104,119)(H,105,115)(H,106,120)
InChIKeyJEAATSIDCJJYDS-UHFFFAOYSA-N
MW1728.31 g/mol
LogP8.17
Rot. Bonds67

About [4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate

[4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate (PubChem CID 158889244) has the molecular formula C92H142N16O14S and a molecular weight of 1728.31 g/mol. Its IUPAC name is [4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate.

Molecular Properties

Compound Name[4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate
PubChem CID158889244
Molecular FormulaC92H142N16O14S
Molecular Weight1728.31 g/mol
Exact Mass1727.06
IUPAC Name[4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate
SMILESCCCCCCCCCCCCCCCCNC(=O)CN(CC)C(=O)CCCCCCC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCCNC(N)N)CC(=O)C(CS)NC(=O)C(CCCNC(N)N)CC(=O)C1CCCN(C(=O)C(NC(=O)C(CC(=O)C(NC(=O)CCCOC=O)C(C)O)Cc2cnc[nH]2)C(c2ccccc2)c2ccccc2)C1
InChIInChI=1S/C92H142N16O14S/c1-4-6-7-8-9-10-11-12-13-14-15-16-19-30-47-98-82(116)60-107(5-2)83(117)46-27-18-17-26-44-77(111)75(53-71-57-101-74-43-29-28-42-73(71)74)103-87(118)68(40-32-49-100-92(95)96)55-79(113)76(61-123)104-88(119)67(39-31-48-99-91(93)94)54-78(112)69-41-33-50-108(59-69)90(121)86(84(65-35-22-20-23-36-65)66-37-24-21-25-38-66)106-89(120)70(52-72-58-97-62-102-72)56-80(114)85(64(3)110)105-81(115)45-34-51-122-63-109/h20-25,28-29,35-38,42-43,57-58,62-64,67-70,75-76,84-86,91-92,99-101,110,123H,4-19,26-27,30-34,39-41,44-56,59-61,93-96H2,1-3H3,(H,97,102)(H,98,116)(H,103,118)(H,104,119)(H,105,115)(H,106,120)
InChIKeyJEAATSIDCJJYDS-UHFFFAOYSA-N
XLogP8.17
TPSA473.54 Ų
H-Bond Donors15
H-Bond Acceptors22
Rotatable Bonds67
Heavy Atoms123
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001728.31
LogP ≤ 58.17
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'thiol_2', 'substructure': 'N/A'}

Analyze [4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate?
The IUPAC name of [4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate (CID 158889244) is [4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate.
What is the SMILES notation for [4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate?
The canonical SMILES for [4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate is CCCCCCCCCCCCCCCCNC(=O)CN(CC)C(=O)CCCCCCC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCCNC(N)N)CC(=O)C(CS)NC(=O)C(CCCNC(N)N)CC(=O)C1CCCN(C(=O)C(NC(=O)C(CC(=O)C(NC(=O)CCCOC=O)C(C)O)Cc2cnc[nH]2)C(c2ccccc2)c2ccccc2)C1.
What is the InChIKey of [4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate?
The InChIKey is JEAATSIDCJJYDS-UHFFFAOYSA-N. The full InChI is InChI=1S/C92H142N16O14S/c1-4-6-7-8-9-10-11-12-13-14-15-16-19-30-47-98-82(116)60-107(5-2)83(117)46-27-18-17-26-44-77(111)75(53-71-57-101-74-43-29-28-42-73(71)74)103-87(118)68(40-32-49-100-92(95)96)55-79(113)76(61-123)104-88(119)67(39-31-48-99-91(93)94)54-78(112)69-41-33-50-108(59-69)90(121)86(84(65-35-22-20-23-36-65)66-37-24-21-25-38-66)106-89(120)70(52-72-58-97-62-102-72)56-80(114)85(64(3)110)105-81(115)45-34-51-122-63-109/h20-25,28-29,35-38,42-43,57-58,62-64,67-70,75-76,84-86,91-92,99-101,110,123H,4-19,26-27,30-34,39-41,44-56,59-61,93-96H2,1-3H3,(H,97,102)(H,98,116)(H,103,118)(H,104,119)(H,105,115)(H,106,120).
What are the key properties of [4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate?
[4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate has a molecular weight of 1728.31 g/mol, XLogP of 8.17, 67 rotatable bonds, 15 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[[7-[[1-[3-[6-(diaminomethylamino)-3-[[8-(diaminomethylamino)-5-[[10-[ethyl-[2-(hexadecylamino)-2-oxoethyl]amino]-1-(1H-indol-3-yl)-3,10-dioxodecan-2-yl]carbamoyl]-3-oxo-1-sulfanyloctan-2-yl]carbamoyl]hexanoyl]piperidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]-2-hydroxy-6-(1H-imidazol-5-ylmethyl)-4,7-dioxoheptan-3-yl]amino]-4-oxobutyl] formate is sourced from PubChem (CID 158889244), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).